TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 8.58 +0.02 (0.23%)
Previous Close $8.56    52 Week High
Open $8.45    52 Week Low
Day High $8.65    P/E N/A 
Day Low $8.01    EPS
Volume 17,233